Navigation Links
Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
Date:9/23/2008

The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. The drug's manufacturer issued a nationwide Digitek recall after receiving several reports of injuries or illnesses among patients.

Austin, Texas (Vocus) September 23, 2008 -- The law firm of Hissey Kientz, LLP has announced the launch of its new website, Digitek Recall Help (http://www.digitekrecallhelp.com). This site will serve as a news and information resource for patients who may have been prescribed the improperly manufactured Digitek (digoxin) tablets that were recently recalled by their maker, Actavis Totowa.

Digitek is a form of the heart medication digoxin, which is used to treat patients with an irregular heartbeat or congestive heart failure. Digitek and other digoxin drugs work by increasing the amount of calcium in the muscles of the heart, which helps to strengthen a patient’s heartbeat. These drugs also work to slow the signals which cause the heart to beat, decreasing the number of irregular heartbeats, or arrhythmias.

Actavis issued a nationwide http://www.digitekrecallhelp.com/Recall.aspx [Digitek recall] on April 25, 2008 after receiving several reports of injuries or illnesses among patients who were taking the drug. According to a press release issued by the company, some Digitek tablets were improperly manufactured at twice their normal thickness. As a result, some patients who were prescribed Digitek may have inadvertently received a double-dose of the drug.

Because the difference between a safe and unsafe amount of Digitek is very small, taking these double-strength pills could cause patients to suffer an overdose due to digoxin toxicity. In some cases, patients who experience a Digitek overdose may suffer a heart attack, stroke or, potentially, death. Other side effects include dizziness and fainting, an irregular heartbeat, low blood pressure, confusion, vomiting, nausea or other symptoms.

In 2006 and 2007, the Food and Drug Administration sent warning letters to Actavis concerning violations of “Good Manufacturing Practices” at the New Jersey plant where Digitek was manufactured. The agency stated that because of these violations, products manufactured at the plant were “adulterated,” meaning that there was no way for the company to make sure that these drugs had the correct “identity, strength, quality and purity” before they were prescribed to patients.

Dozens of individuals who developed serious and potentially deadly injuries after suffering a Digitek overdose have already contacted an http://www.digitekrecallhelp.com/Lawsuits/A_Digitek_Attorney_Can_Help.aspx [attorney] about filing a lawsuit against Actavis Totowa and its distributors. These lawsuits have alleged that Digitek tablets were defectively manufactured at twice their normal dose by Actavis. Patients have also alleged that the company failed to heed safety warnings from the FDA about quality control issues at the plant where Digitek was produced, which may have contributed to the Digitek recall.

About Hissey Kientz, LLP
http://www.hkllp.com/ [Hissey Kientz, LLP] is currently accepting cases involving individuals who may have been injured as a result of a Digitek overdose. Hissey Kientz, LLP also represents those who contracted mesothelioma or lung cancer as a result of asbestos exposure, and those injured by the Ortho Evra patch, Trasylol, the Composix Kugel mesh patch, the Duragesic patch (fentanyl), gadolinium MRI contrast dyes or other defective drugs and devices. To learn more about the firm and other drug cases, visit Hissey Kientz, LLP (www.hkllp.com) or call toll-free at (866) 275-4454.

###

Read the full story at http://www.prweb.com/releases///prweb1370794.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Hissey Kientz Concerned That Patients Have Not Been Provided With Crucial Information About Digitek Recall Despite the Dangers of Digoxin Toxicity
2. LifeMasters Announces Agreement to Offer Disease Management Services to High-Risk Wisconsin Residents
3. Hanger Orthopedic Group, Inc. Announces Underwritten Public Offering by Shareholder
4. Satellite Healthcare Announces 2008 Norman S. Coplon Extramural Grants : Grants Foster Next-Generation Kidney Disease Researchers
5. Natural Alternatives International, Inc. Announces Fiscal 2008 Results
6. Arrowsight Announces Appointment of Suzanne Delbanco as President of Health Care Division
7. Radiation Oncology Services of America, Inc. Announces Formation of Scientific Advisory Board
8. CorVel Announces Expanded Share Buyback
9. Lucas Group Announces Their Military Hiring Conferences Schedule for September
10. Integrative Nutrition Announces Partnership with SUNY
11. iMedica Announces Agreement with Misys
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hissey Kientz, LLP Announces the Launch of Digitek Recall Help Web Site
(Date:6/24/2016)... ... 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida ... their peers for this recognition are considered among the top 2 percent of lawyers ... as members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening their ... Award, an essay contest in which patients and their families pay tribute to a ... the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. ...
(Date:6/24/2016)... York, NY (PRWEB) , ... June 24, 2016 ... ... publication Haute Living, is proud to recognize Dr. Barry M. Weintraub as a ... that “the most beautiful women in the world, and the most handsome men, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... PARK RIDGE, Ill. and INDIANAPOLIS ... caliber of students receiving a Lilly Diabetes Tomorrow,s Leaders ... hands. The 2016 scholarship winners, announced today online at ... refused to let type 1 diabetes stand in the ... Lilly Diabetes has supported the Foundation,s scholarship program since ...
Breaking Medicine Technology: